Munawar DA, Mahajan R, Agbaedeng TA, Thiyagarajah A, Twomey DJ, Khokhar K, et al
For obesity therapeutics, Phase 3 trials are especially important because regulators want to see: Long-term weight loss sustainability Cardiovascular safety Real-world tolerability Effects on obesity-related conditions such as diabetes, sleep apnea, and osteoarthritis Retatrutides Phase 3 program, called TRIUMPH , includes multiple large-scale studies across different patient populations
It therefore plays an important role in energy metabolism, by promoting energy efficiency and production at cell level
KumarDPAsgharpourAMirshahiFParkSHLiuSImaiYet al
Many People Using GLP-1 Weight Loss Drugs May Not Be Eating Enough Nutritious Food. UCHealth Today, 19 May 2025
The antifolate activity of tea catechins